Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amlodipine vs Valsartan for Diastolic Dysfunction in Hypertension
NCT02973035Phase 4Completed
- Sponsor
- Asan Medical Center
- Start
- Dec 2016
- Primary completion
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of amlodipine in hypertension (HTN) and diastolic dysfunction (2 arms), sponsored by Asan Medical Center. Primary endpoint: Change in the ratio of E velocity to E' velocity at 24 weeks. Started Dec 2016; status: completed.
02
Drugs
amlodipine
03
Conditions
hypertension (HTN)diastolic dysfunction
Beyond the preview
Go deeper on NCT02973035.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02973035.